The goal of this program is to raise awareness in front-line clinicians—primary care physicians, nurse practitioners, and physician assistants—of the need to discuss the importance of consistently receiving eye exams with their Latino/Hispanic patients with diabetes.
After completing this activity, participants should be better able to:
- Discuss the unmet need for improved diabetic eye care in the Latino/Hispanic community
- Outline risks associated with delayed intervention in patients with diabetic eye disease
- Describe standards of care and preferred practice patterns for screening and diagnosing diabetic eye disease
- Explain the benefits of timely anti-vascular endothelial growth factor treatments for patients with diabetic macular edema and diabetic retinopathy
NPs, PAs, and physicians
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO) and Infinity Medical Education. Clinical Care Options, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
ACCME Credit Designation
CCO designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA Credit Designation
Clinical Care Options has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credit. Approval is valid until January 7, 2022. PAs should only claim credit commensurate with the extent of their participation.
AANP Credit Designation
This activity is approved for 0.5 contact hour(s) of continuing education (which includes 0.15 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 21014686. This activity was planned in accordance with AANP Accreditation Standards and Policies.
This activity is supported by an educational grant from Regeneron Pharmaceuticals.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Dr Rishi P. Singh receives grants and research support from Apellis and Graybug.
Dr Singh receives consulting fees from Alcon, Bausch and Lomb, Genentech, Novartis, Optos, Regeneron, and Zeiss.
None of the planners or members of the CCO staff have any relevant relationships to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants wishing to earn CE/CME credit must:
- View the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 66%.
The estimated time to complete this activity is 0.50 hours.
Release date: January 8, 2021
Expiration date: January 7, 2022
© 2021 Practicing Clinicians Exchange. All Rights Reserved. 101320IF